Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dobmeier Eric
Relationship:   President, CEO, Director
City:   Bothell
State:   WA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   730,812    

Indirect Shares

   0      
Direct Value   $28,069,465    

Indirect Value

   $0      
Total Shares   730,812      
Total Value   $28,069,465      


Seagen Inc $27,416,776 Stemline Therapeutics Inc $330,802 Atara Biotherapeutics, Inc. $315,969 Aravive Inc $728 Adaptive Biotechnologies Corp $5,189 Seagen Inc $27,416,776 Stemline Therapeutics Inc $330,802 Atara Biotherapeutics, Inc. $315,969 Aravive Inc $728 Adaptive Biotechnologies Corp $5,189
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    3    

     Stock price went up :
    7   
    3    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   1.2   
   3.0   
     Percentage Gain/Loss :
   17.0%
 198.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Chief Operating Officer 2017-12-04 119,860 2004-05-05 0    Premium*  
            Stemline Therapeutics Inc STML Director 2017-06-19 27,963 0    Premium*  
            Atara Biotherapeutics, Inc. ATRA 2023-11-10 563,325 2015-12-16 0    Premium*  
            Aravive Inc ARAV Director 2017-12-20 18,160 2017-05-25 0    Premium*  
            Adaptive Biotechnologies Corp ADPT Director 2021-02-14 1,504 2019-12-26 0    Premium*  
            Chinook Therapeutics Inc KDNY President, CEO, Director 2023-08-11 0 2020-10-05 0    Premium*  
* Premium Members only  

Records found :    177         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Chief Operating Officer   •       –      –    2011-06-20 4 AS $20.00 $267,700 D/D (13,385) 8,817 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2011-10-20 4 AS $20.58 $421,024 D/D (20,461) 59,327 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2011-10-27 4 AS $21.95 $459,150 D/D (20,918) 59,327 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-04-25 4 AS $19.95 $498,750 D/D (25,000) 68,073 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-06-18 4 AS $25.36 $634,000 D/D (25,000) 68,073 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-08-13 4 AS $24.01 $600,290 D/D (25,000) 43,352 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-10-15 4 AS $25.01 $625,295 D/D (25,000) 69,352 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2012-12-17 4 AS $23.70 $1,184,955 D/D (50,000) 113,829 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2013-01-04 4 AS $24.95 $1,272,026 D/D (50,983) 122,846 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2013-08-19 4 AS $40.91 $136,148 D/D (3,328) 109,620 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2014-01-21 4 AS $47.87 $2,683,958 D/D (56,010) 77,833 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2014-08-25 4 AS $43.55 $209,819 D/D (4,818) 73,432 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2015-08-20 4 AS $42.02 $359,226 D/D (8,548) 74,407 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2016-08-22 4 AS $46.59 $252,102 D/D (5,411) 67,525 0 -
SGEN Seagen Inc Chief Operating Officer   •       –      –    2017-08-28 4 AS $47.89 $255,900 D/D (5,343) 117,424 0 -
ADPT Adaptive Biotechnologies ... Director   –       •      –    2019-12-26 4/A AS $29.29 $439,351 D/D (15,000) 0 0 -
ADPT Adaptive Biotechnologies ... Director   –       •      –    2019-12-31 4/A AS $30.00 $150,000 D/D (5,000) 0 0 -
ADPT Adaptive Biotechnologies ... Director   –       •      –    2020-05-07 4 AS $35.00 $175,000 D/D (5,000) 0 0 %
ADPT Adaptive Biotechnologies ... Director   –       •      –    2020-05-19 4 AS $40.00 $200,000 D/D (5,000) 0 0 %
ADPT Adaptive Biotechnologies ... Director   –       •      –    2020-07-06 4 AS $47.34 $473,656 D/D (10,000) 0 0 %
ADPT Adaptive Biotechnologies ... Director   –       •      –    2020-10-01 4 AS $48.47 $485,274 D/D (10,000) 0 0 %
ADPT Adaptive Biotechnologies ... Director   –       •      –    2021-01-04 4 AS $56.10 $573,369 D/D (10,000) 0 0 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2022-12-01 4 AS $22.31 $669,351 D/D (30,000) 241,676 0 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2023-01-30 4 AS $24.54 $613,613 D/D (25,000) 271,676 0 %
KDNY Chinook Therapeutics Inc President, CEO   •       •      –    2023-01-31 4 AS $24.68 $189,757 D/D (7,688) 288,987 0 %
  177  Records found
  1   2  3   4   5   6   7   8      
  Page 2 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us